WO1996005797A2 - Agent for external application with nutrient and protective properties - Google Patents
Agent for external application with nutrient and protective properties Download PDFInfo
- Publication number
- WO1996005797A2 WO1996005797A2 PCT/UA1995/000005 UA9500005W WO9605797A2 WO 1996005797 A2 WO1996005797 A2 WO 1996005797A2 UA 9500005 W UA9500005 W UA 9500005W WO 9605797 A2 WO9605797 A2 WO 9605797A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substances
- agent
- biogenic
- skin
- amount
- Prior art date
Links
- 235000015097 nutrients Nutrition 0.000 title abstract 4
- 230000001681 protective effect Effects 0.000 title abstract 3
- 239000000126 substance Substances 0.000 claims abstract description 20
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 16
- 230000000035 biogenic effect Effects 0.000 claims abstract description 8
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 8
- 239000002537 cosmetic Substances 0.000 claims abstract description 7
- 108010019160 Pancreatin Proteins 0.000 claims abstract description 6
- 229940055695 pancreatin Drugs 0.000 claims abstract description 6
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims abstract description 4
- 229960000342 retinol acetate Drugs 0.000 claims abstract description 3
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims abstract description 3
- 235000019173 retinyl acetate Nutrition 0.000 claims abstract description 3
- 239000011770 retinyl acetate Substances 0.000 claims abstract description 3
- 239000000739 antihistaminic agent Substances 0.000 claims abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 claims description 3
- 230000009471 action Effects 0.000 claims description 3
- 229960002061 ergocalciferol Drugs 0.000 claims description 3
- 235000001892 vitamin D2 Nutrition 0.000 claims description 3
- 239000011653 vitamin D2 Substances 0.000 claims description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 2
- 229930194270 alpha-Vitamin Natural products 0.000 claims description 2
- 235000005911 diet Nutrition 0.000 claims description 2
- 230000000378 dietary effect Effects 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 208000017667 Chronic Disease Diseases 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- NYRAVIYBIHCEGB-UHFFFAOYSA-N [K].[Ca] Chemical compound [K].[Ca] NYRAVIYBIHCEGB-UHFFFAOYSA-N 0.000 claims 1
- 229940124277 aminobutyric acid Drugs 0.000 claims 1
- 229940035674 anesthetics Drugs 0.000 claims 1
- 229940124623 antihistamine drug Drugs 0.000 claims 1
- 239000003193 general anesthetic agent Substances 0.000 claims 1
- 239000000383 hazardous chemical Substances 0.000 claims 1
- 239000002304 perfume Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 12
- 239000000203 mixture Substances 0.000 abstract description 11
- 230000032683 aging Effects 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 206010047642 Vitiligo Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 abstract 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract 1
- 241000723346 Cinnamomum camphora Species 0.000 abstract 1
- 206010027146 Melanoderma Diseases 0.000 abstract 1
- 241000209295 Melanoderma Species 0.000 abstract 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 abstract 1
- 229960002079 calcium pantothenate Drugs 0.000 abstract 1
- 229960000846 camphor Drugs 0.000 abstract 1
- 229930008380 camphor Natural products 0.000 abstract 1
- 238000005336 cracking Methods 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 229940000033 dermatological agent Drugs 0.000 abstract 1
- 239000003241 dermatological agent Substances 0.000 abstract 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 239000000049 pigment Substances 0.000 abstract 1
- 230000000451 tissue damage Effects 0.000 abstract 1
- 231100000827 tissue damage Toxicity 0.000 abstract 1
- 235000019155 vitamin A Nutrition 0.000 abstract 1
- 239000011719 vitamin A Substances 0.000 abstract 1
- 229940045997 vitamin a Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 24
- 210000003491 skin Anatomy 0.000 description 22
- 239000000306 component Substances 0.000 description 14
- 230000006872 improvement Effects 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 229940079593 drug Drugs 0.000 description 6
- 235000019271 petrolatum Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 210000000744 eyelid Anatomy 0.000 description 5
- 210000001061 forehead Anatomy 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 239000003925 fat Substances 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 3
- 239000004264 Petrolatum Substances 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 229940066842 petrolatum Drugs 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 206010000372 Accident at work Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 206010020112 Hirsutism Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 230000003167 anti-vitamin Effects 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 210000004227 basal ganglia Anatomy 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000001083 documented effect Effects 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000002276 neurotropic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- CBXWGGFGZDVPNV-UHFFFAOYSA-N so4-so4 Chemical compound OS(O)(=O)=O.OS(O)(=O)=O CBXWGGFGZDVPNV-UHFFFAOYSA-N 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- the modern destructive method has a variety of healthy foods that are characterized by a separate and variable appliance.
- P ⁇ s ⁇ avlennaya task ⁇ eshae ⁇ sya ⁇ em, ch ⁇ na ⁇ uzhn ⁇ e de ⁇ ma ⁇ l ⁇ giches ⁇ e s ⁇ eds ⁇ v ⁇ , s ⁇ de ⁇ zhaschee zhi ⁇ vuyu ⁇ sn ⁇ vu, ⁇ izv ⁇ dn ⁇ e ⁇ sibenz ⁇ yn ⁇ y ⁇ isl ⁇ y, vi ⁇ amin ⁇ and v ⁇ du, s ⁇ glasn ⁇ iz ⁇ b ⁇ e ⁇ eniyu 5 ⁇ aches ⁇ ve ⁇ izv ⁇ dn ⁇ g ⁇ ⁇ sibenz ⁇ yn ⁇ y ⁇ isl ⁇ y, s ⁇ de ⁇ zhi ⁇ salitsil ⁇ vuyu ⁇ isl ⁇ u or ⁇ izv ⁇ dnye and d ⁇ lni ⁇ eln ⁇ s ⁇ de ⁇ zhi ⁇ ⁇ am ⁇ u ⁇ av ⁇ v ⁇ aschayuschuy
- Vitamin D2 (ergocalysis) - 0.000625 - 0.00125
- Salicylic acid having a high lipidity and the ability to dispel the epidemic of the skin, as well as to have a positive effect on the activity of
- G ⁇ e ⁇ giches ⁇ i ⁇ , d ⁇ amine ⁇ giches ⁇ i ⁇ vesches ⁇ v and ⁇ - ⁇ lin ⁇ li ⁇ i ⁇ v v ⁇ z ⁇ as ⁇ ala ⁇ i s ⁇ che ⁇ ann ⁇ m i ⁇ is ⁇ lz ⁇ vanii with ⁇ a ⁇ imi bi ⁇ gennymi s ⁇ imulya ⁇ ami, ⁇ a ⁇ ⁇ an ⁇ ea ⁇ in and vi ⁇ aminny ⁇ m ⁇ le ⁇ s, ⁇ eds ⁇ avlenny vi ⁇ aminami ⁇ , D2, and as ⁇ bin ⁇ v ⁇ y ⁇ isl ⁇ y ⁇ altsiya ⁇ an ⁇ ena ⁇ m.
- the pharmaceutical product is included in the composition of the proposed external medical product in mass. 1.0 - 2.0.
- dimexide may be included in the amount of 1.0 - 3.0 wt. %
- E ⁇ ⁇ s ⁇ benn ⁇ vazhn ⁇ ⁇ i is ⁇ lz ⁇ vanii s ⁇ eds ⁇ va in case ⁇ vy ⁇ azhenny ⁇ dis ⁇ iches ⁇ i ⁇ changes in ⁇ zhe and na ⁇ usheny ⁇ anev ⁇ y ⁇ e ⁇ uzii. 9
- ⁇ ⁇ aches ⁇ ve zhi ⁇ v ⁇ y ⁇ sn ⁇ vy m ⁇ zhe ⁇ by ⁇ is ⁇ lz ⁇ vana any ⁇ ig ⁇ dnaya for de ⁇ ma ⁇ l ⁇ ches ⁇ g ⁇ ⁇ sme ⁇ iches ⁇ g ⁇ s ⁇ eds ⁇ va ⁇ m ⁇ zitsiya zhi ⁇ v and na ⁇ u ⁇ alny ⁇ and sin ⁇ e ⁇ iches ⁇ i ⁇ zhi ⁇ d ⁇ bny ⁇ vesches ⁇ v - lan ⁇ lina, s ⁇ e ⁇ matse ⁇ a, masl ⁇ - ⁇ a ⁇ a ⁇ , ⁇ chelin ⁇ g ⁇ v ⁇ s ⁇ a, ⁇ as ⁇ i ⁇ elny ⁇ oils, petrolatum and d ⁇ . in wt. % 30.0 - 70.0, as an emulsified fat system, the type "water-oil” and the type "oil-water” can be supplied.
- a home-brewed property with a potent responsive effect may optionally contain a scent in the amount of 0.5 to 1.5 wt. %, on the other hand, lavender oil, industrial oil and other products are used in good quality;
- a homemade device with a safe operation is prepared by the following:
- an emulsified fat complex with active biological additives is obtained (mixture 2). With frequent intensive stirring, mix the mixture 1 and 2 and add the oil products of vitamins ⁇ and D2, the scent. In view of the increased need for greater stabilization of the emulsion system, the corresponding emulsifier is used.
- the ready-to-use medical device which has a safe operation, is free from temperature of 4 ° - 8 ° C in the case of the court, which is supplied by the manufacturer.
- the spray was applied to the cleaned skin of the face and neck for 30 - 40 minutes.
- the rest After the indicated expiration of the rest, the rest is soft and comfortable. 12 movements were filmed with a paper napkin. Chases with krem were made daily, on the eve of 30 mass.
- This external device is equipped with a radioactive device.
- Gastrointestinal devel- opment is associated with an increase in the activity of dehydrogendehyde associated with oxidatively-active diseases.
- the accumulated external equipment which is dominant in terms of performance, is highly efficient due to the successful delivery.
- ⁇ n ⁇ with us ⁇ e ⁇ m m ⁇ zhe ⁇ by ⁇ is ⁇ lz ⁇ van ⁇ in ⁇ aches ⁇ ve de ⁇ ma ⁇ l ⁇ giches ⁇ g ⁇ ⁇ sme ⁇ iches ⁇ g ⁇ s ⁇ eds ⁇ va for us ⁇ aneniya ⁇ azlichny ⁇ ⁇ sme ⁇ iches ⁇ i ⁇ ned ⁇ s ⁇ a ⁇ v ⁇ zhi, svyazanny ⁇ with na ⁇ usheniem its ⁇ i ⁇ i and ⁇ bmena vesches ⁇ v: s ⁇ a ⁇ eniya and withering ⁇ zhi, is ⁇ ncheniya, su ⁇ s ⁇ i, zhes ⁇ s ⁇ i, peeling, ⁇ nizheniya u ⁇ ug ⁇ s ⁇ i and elas ⁇ ichn ⁇ s ⁇ i.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95944700A EP0771555B1 (en) | 1994-08-03 | 1995-08-03 | Agent for external application with nutrient and protective properties |
DE69523925T DE69523925D1 (de) | 1994-08-03 | 1995-08-03 | Wirkstoff zur äusserlichen anwendung mit nähr- und schutzeigenschaften |
US08/776,575 US5817621A (en) | 1994-08-03 | 1995-08-03 | External remedy possessing trophoprotective effect |
AU33586/95A AU3358695A (en) | 1994-08-03 | 1995-08-03 | Agent for external application with nutrient and protective properties |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UA94086487 | 1994-08-03 | ||
UA94086487A UA10208A (ru) | 1994-08-03 | 1994-08-03 | Дерматологическое косметическое средство |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996005797A2 true WO1996005797A2 (en) | 1996-02-29 |
WO1996005797A3 WO1996005797A3 (fr) | 1996-04-11 |
Family
ID=21689001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/UA1995/000005 WO1996005797A2 (en) | 1994-08-03 | 1995-08-03 | Agent for external application with nutrient and protective properties |
Country Status (7)
Country | Link |
---|---|
US (1) | US5817621A (ru) |
EP (1) | EP0771555B1 (ru) |
AU (1) | AU3358695A (ru) |
CA (1) | CA2196547A1 (ru) |
DE (1) | DE69523925D1 (ru) |
UA (1) | UA10208A (ru) |
WO (1) | WO1996005797A2 (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2746008A1 (fr) * | 1996-03-14 | 1997-09-19 | Thorel Jean Noel | Composition a usage topique anti-vieillissement |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5958976A (en) * | 1997-09-19 | 1999-09-28 | E-L Management Corp. | Composition and method for reducing stinging in skin |
FR2790667B1 (fr) * | 1999-03-10 | 2002-06-14 | Oreal | Produit pour application topique sur la peau comprenant un ester de retinyle et un sel de metal alcalino-terreux |
DE10148827B4 (de) * | 2001-10-04 | 2004-12-09 | Beiersdorf Ag | Ascorbinsäurehaltige O/W-Emulsionen, diese enthaltende kosmetische und/oder dermatologische Zubereitungen, deren Verwendung sowie Verfahren zu ihrer Herstellung |
US20030165546A1 (en) * | 2002-03-04 | 2003-09-04 | The Procter & Gamble Company | Stable personal care compositions containing a retinoid |
JP4473491B2 (ja) * | 2002-05-28 | 2010-06-02 | 株式会社資生堂 | 毛穴縮小剤 |
US7115563B2 (en) | 2002-05-29 | 2006-10-03 | Insignion Holding Limited | Composition and its therapeutic use |
US7306810B1 (en) | 2002-11-25 | 2007-12-11 | Piedmont Cosmeceuticals, Inc. | Skin cream |
FR2909280B1 (fr) * | 2006-11-30 | 2015-04-17 | Marcel Georges Cohen | Utilisation de l'acide gamma-aminobutyrique en tant qu'agent depigmentant |
EP2228050A1 (fr) * | 2009-03-09 | 2010-09-15 | Marcel Cohen | Utilisation de l'acide gamma-aminobutyrique en tant qu'agent dépigmentant |
WO2012006107A2 (en) | 2010-06-28 | 2012-01-12 | Stemtide, Inc. | Skin care compositions |
US9216209B1 (en) * | 2011-06-06 | 2015-12-22 | Kilmer S. McCully | Compositions and method for utilization of thioretinamide in therapy of degenerative diseases of aging |
WO2013091894A2 (en) | 2011-12-21 | 2013-06-27 | Flavin Dana | Topical compositions |
JP6121199B2 (ja) * | 2013-03-08 | 2017-04-26 | 富士フイルム株式会社 | メラニン産生抑制剤、メラノソームトランスファー抑制剤及び美白剤 |
FR3017290B1 (fr) * | 2014-02-10 | 2017-05-12 | Dermaconcept Jmc | Composition pour lutter contre la chute des cheveux |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2492659A1 (fr) * | 1980-10-27 | 1982-04-30 | Wiel Gaston | Composition destinee a etre utilise |
US4369180A (en) * | 1981-09-10 | 1983-01-18 | Randolph C. Karrh | Cosmetic facial preparation containing aloe vera |
FR2521005A1 (fr) * | 1982-02-09 | 1983-08-12 | Wiel Gaston | Composition pour les soins et le rajeunissement de la peau, produits cosmetiques obtenus a l'aide de ladite composition et procede pour sa fabrication |
FR2557452B1 (fr) * | 1983-12-28 | 1986-08-14 | Roussel Uclaf | Nouvelles compositions pour les soins de la peau renfermant de l'huile d'onagre et des traits tissulaires de rate |
JPS60184005A (ja) * | 1984-03-02 | 1985-09-19 | Kanebo Ltd | 皮膚老化防止用化粧料 |
CA1249968A (en) * | 1984-04-05 | 1989-02-14 | Kazuo Kigasawa | Ointment base |
DE3514724A1 (de) * | 1985-04-24 | 1986-10-30 | Albin F. Dr. 4200 Oberhausen Jereb | Salbe zur verbeugung und behandlung von augen- und hauterkrankungen |
LU87145A1 (fr) * | 1988-02-26 | 1989-09-20 | Oreal | Methode pour ameliorer l'aspect esthetique de la peau a l'aide de melanges polyvitaminiques |
US5446070A (en) * | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
CH670951A5 (en) * | 1988-06-13 | 1989-07-31 | Paul Dr Med Herzog | Cosmetic, cicatrising and disinfectant emulsions - contain vitamin=A ester and hydrogen peroxide |
LU87408A1 (fr) * | 1988-12-16 | 1990-07-10 | Oreal | Utilisation de derives salicyles pour le traitement du vieillissement de la peau |
US5013726A (en) * | 1989-09-12 | 1991-05-07 | Ivy Jeffery W | External analgesic lotion containing active ingredients of methyl salicylate and camphor and menthol and method of making such lotion |
WO1993010755A1 (en) * | 1991-11-25 | 1993-06-10 | Richardson-Vicks, Inc. | Compositions for regulating skin wrinkles and/or skin atrophy |
EP0639068A1 (en) * | 1992-05-05 | 1995-02-22 | The Procter & Gamble Company | Acne treating composition |
JPH07238010A (ja) * | 1994-02-24 | 1995-09-12 | Kanebo Ltd | 皮膚化粧料 |
-
1994
- 1994-08-03 UA UA94086487A patent/UA10208A/ru unknown
-
1995
- 1995-08-03 CA CA002196547A patent/CA2196547A1/en not_active Abandoned
- 1995-08-03 EP EP95944700A patent/EP0771555B1/en not_active Expired - Lifetime
- 1995-08-03 DE DE69523925T patent/DE69523925D1/de not_active Expired - Lifetime
- 1995-08-03 AU AU33586/95A patent/AU3358695A/en not_active Abandoned
- 1995-08-03 US US08/776,575 patent/US5817621A/en not_active Expired - Fee Related
- 1995-08-03 WO PCT/UA1995/000005 patent/WO1996005797A2/ru active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2746008A1 (fr) * | 1996-03-14 | 1997-09-19 | Thorel Jean Noel | Composition a usage topique anti-vieillissement |
Also Published As
Publication number | Publication date |
---|---|
EP0771555B1 (en) | 2001-11-14 |
CA2196547A1 (en) | 1996-02-29 |
UA10208A (ru) | 1996-12-25 |
EP0771555A2 (en) | 1997-05-07 |
AU3358695A (en) | 1996-03-14 |
EP0771555A4 (en) | 1998-04-01 |
US5817621A (en) | 1998-10-06 |
DE69523925D1 (de) | 2001-12-20 |
WO1996005797A3 (fr) | 1996-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996005797A2 (en) | Agent for external application with nutrient and protective properties | |
JP6894991B2 (ja) | 有効成分としてミントビネガーを含有する化粧料組成物 | |
US5972340A (en) | Slimming cream based on plants | |
RU2126687C1 (ru) | Лекарственное средство, обладающее желчегонным действием | |
Grigoriev | Application of hempseed (Cannabis sativa L.) oil in the treatment of ear, nose and throat (ENT) disorders | |
RU2163481C1 (ru) | Крем-бальзам пихтовый и его варианты | |
KR100505486B1 (ko) | 바이오 신물질 소재를 이용한 섬유소재와 그 제조방법 | |
ES2672314B1 (es) | Ingrediente farmacéutico activo (IFA) oleoso para el tratamiento de afecciones de la piel, composiciones que lo comprenden y su uso para prepararlas | |
CN110559314A (zh) | 一种保护视力的组合物 | |
RU2191000C2 (ru) | Косметическая маска | |
CN109954052A (zh) | 一种具有抗氧化活性的组合物 | |
DE4310015A1 (de) | Mittel zur Pflege der menschlichen Haut | |
CN100457150C (zh) | 缓解视疲劳的胶囊或片剂及其制备方法 | |
RU2222316C2 (ru) | Лечебно-косметическое средство | |
RU2129434C1 (ru) | Линимент "камфоцитол" | |
RU2186561C2 (ru) | Крем для сухой и нормальной кожи лица | |
RU2148397C1 (ru) | Мазь для лечения заболеваний и повреждений кожи | |
US20190365735A1 (en) | Compositions and methods for treating varicose veins | |
Cohen | Essential Oils to Boost the Brain and Heal the Body: 5 Steps to Calm Anxiety, Sleep Better, and Reduce Inflammation to Regain Control of Your Health | |
RU2825001C1 (ru) | Средство для лечения ожогов | |
Husain | Shahnaz Husain's Beauty Book | |
Wood | A System of ophthalmic therapeutics | |
CN100411627C (zh) | 一种治疗面部皮炎脱敏的面膜 | |
RU2233159C1 (ru) | Лечебно-профилактическое и косметическое средство для ухода за кожей (варианты) | |
CN114340613A (zh) | 治疗特应性皮炎的组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BG BR BY CA CN CZ ES HU JP KG KR KZ LT LU LV PL RO RU SK TJ US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BG BR BY CA CN CZ ES HU JP KG KR KZ LT LU LV PL RO RU SK TJ US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2196547 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08776575 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1995944700 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 1995944700 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1995944700 Country of ref document: EP |